Tagged with R

Romania Simona Cocos of Zentiva Romania explains how the affiliate has developed since its separation from Sanofi and how recent acquisitions have impacted local operations. She shares how the extremely diversified portfolio is a key strength and how new ventures in consumer health are helping boost performance. Cocos adds that continued…

China 2019 was a landmark year for the Chinese healthcare industry.* Since the publication of the ‘Healthy China 2030’ blueprint in 2016 by the Chinese government, the entire sector has been virtually turned upside down. Against the warm backdrop of regulatory support, a series of policy changes were unveiled in the…

Belgium The top 20 pharma companies in Belgium ranked by revenue for the financial year 2019. EG Generics is way out in front with EUR 210 million in revenue, followed by Novartis Pharma and Janssen-Cilag.   Made with Visme Infographic Maker   The top 20 pharma companies in Belgium ranked by…

Romania Highlighting the top 50 pharma companies in Romania by value for the year ending December 2019. Multinationals MSD, Sanofi and Novartis top the list, but regional players such as Romanian firm Antibiotice, Slovenian Krka and Czech-headquartered  Zentiva are also represented.    Made with Visme Infographic Maker

Romania Pascal Robin, country chair of Sanofi and general manager of Sanofi Pasteur for Romania and Moldova, shares his insights on the intrinsic and extrinsic factors that helped Sanofi become a market leader in Romania. He reveals how the affiliate’s well-diversified portfolio is adapted to Romanian needs and how it is…

UAE NewBridge Pharmaceuticals, a specialty pharma company with Dubai as its regional headquarters for the MENA region, is celebrating its 10th anniversary in 2020. President and CEO Joe Henein discusses the company’s journey to becoming the partner of choice for US and European companies looking to bring their innovative products to…

Romania Dominika Kovacs, country manager of Takeda Romania, shares her insights on the growing pipeline of the organisation and the anticipated launch of a state-of-art stem cell therapy. She highlights the organisational changes in the last year, and how they have been inducive to double-digit growth for Takeda. Additionally, she reveals…

Japan In April 2019, Yasuhiro Fujiwara was appointed as the new chief executive of Japan’s drug regulator and one of the world’s foremost regulatory bodies, the Pharmaceuticals and Medical Devices Agency (PMDA). Upon appointment, Fujiwara coined the “Four Fs” strategy, urging PMDA employees to have a “patient first,” “access first,” “safety…

Belgium Luxembourg Brecht Vanneste, associate VP and managing director of MSD in Belgium and Luxembourg, highlights the strategic significance of the affiliate as an important location for early-stage clinical trials and home to the company’s Heist-op-den-Berg production facility, a key manufacturing site for the global group. Vanneste delivers a strong message about…

Czech Republic Kostas Deligiannis, general manager Eastern Europe for GE Healthcare (GEHC), outlines GE Healthcare’s commitment to the 20-country region under his remit, his priorities for greater collaboration between these countries, and how GE Healthcare’s innovations continue to set the bar high for both long term cost savings and improvements to patients’…

Global To celebrate International Women’s Day 2020, PharmaBoardroom brings you insights from some of the most inspirational female industry leaders we have had the privilege of talking to over the past 12 months.   Janet Woodcock, Director, Center for Drug Evaluation and Research (CDER), US FDA     Science really can…

Belgium Teun Grooters, co-founder and CEO of Arega – the exclusive distributor of Teva generics in Belgium – tells the story of the newly founded pharmaceutical company and shares his future ambitions to grow the organization into a multinational player delivering comprehensive solutions in areas with unmet medical needs. Grooters also…